TY  - RPRT
TI  - TP53 mutations in endometrial cancer contribute to clinically-relevant radiation resistance and highlight the potential for biomarker-driven radiosensitization strategies.
AU  - Vargas, R.
AU  - Petty, A.
AU  - Yard, B.
AU  - Durmaz, A.
AU  - Lin-Rahardja, K.
AU  - Scott, J.
PY  - 2022
DO  - 10.1101/2022.09.06.505009
UR  - https://www.biorxiv.org/content/10.1101/2022.09.06.505009v1
ID  - 10.1101/2022.09.06.505009
ER  -